The Healthcare Cost Burden in Adults with High Risk for Cardiovascular Disease

Little is currently known about the overall health service utilization and cost burden in patients with high risk for cardiovascular disease (HRCVD) who are recommended to start a statin to control dyslipidemia to prevent CVD events and mortality in short- and long-term care. We assessed the resource use and healthcare cost burden in this HRCVD patient population in Alberta, Canada, and found that healthcare costs associated with the conditions is substantial but decreases over time. The long-term care costs are much less than the costs incurred during the first year after diagnosis